Hepatitis c virus variability: Sequence analysis of an isolate after 10 years of chronic infection

被引:32
作者
Rispeter, K
Lu, MJ
Behrens, SE
Fumiko, C
Yoshida, T
Roggendorf, M
机构
[1] Fundacao Oswaldo Cruz, Dept Virol, Rio De Janeiro, Brazil
[2] Univ Essen Gesamthsch Klinikum, Inst Virol, D-45122 Essen, Germany
[3] Univ Giessen, Inst Virol, FB Vet Med, D-35392 Giessen, Germany
关键词
hepatitis C virus; sequence analysis; variability; anti-D; full-length cDNA; Germany;
D O I
10.1023/A:1008135413215
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hepatitis C virus (HCV) variability was analyzed based upon an isolate which had caused the infection of more than 2500 women in 1978/79. Genome consensus sequences of two isolates obtained from the infectious source (HCV-AD78) and from a chronic hepatitis patient 10 years after the acute infection were determined. The entire open reading frame (ORF) exhibited 3.2 x 10(-3) nucleotide substitutions per site per year (Delta nt). Core (0.7 x 10(-3) Delta nt) and NS5B (1.9 x 10(-3) Delta nt) were found to be most conserved genes, while E2 (4.7 x 10(-3) Delta nt) with hypervariable region 1 (HVR1) (23 x 10(-3) Delta nt) was the most variable followed by p7 (4.2 x 10(-3) Delta nt). In the entire ORF transitions were 4.5 times more frequent than transversions while for the HVR1 this bias was turned. As an indicator of relative selective pressure on the proteins the rates of nonsynonymous to synonymous substitutions (dN/dS) were determined. The obtained values exceeded 1.0 only for E2 (dN/dS=1.3). A subdivision of the entire ORF into 88 overlapping sections, each containing 300 nucleotides, led to a more precise analysis of HCV diversity. Besides for E2 an increased variability was mainly detected for three other regions: (a) the C terminal neighbouring region of E2 including p7, (b) the genome fragment extending from approximately the middle of NS3 to NS4B, and (c) the segment corresponding to the C-terminus of the NS5A protein. The variable region in NS5A was situated carboxyterminal to the predicted interferon sensitivity determining region (ISDR). These results suggest which regions other than HVR1 might contribute to persistence of the virus by the mechanism of immunescape.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [41] Therapeutic vaccination against chronic hepatitis C virus infection
    Ip, Peng Peng
    Nijman, Hans W.
    Wilschut, Jan
    Daemen, Toos
    ANTIVIRAL RESEARCH, 2012, 96 (01) : 36 - 50
  • [42] Iron and Proinflammatory Cytokines in Chronic Hepatitis C Virus Infection
    Lopez-Prieto, Javier
    Gonzalez-Reimers, Emilio
    Remedios Aleman-Valls, M.
    Jose de la Vega-Prieto, Maria
    Abreu-Gonzalez, Pedro
    Pelazas-Gonzalez, Ricardo
    Hernandez-Luis, Ruben
    Jorge-Ripper, Carlos
    Santolaria-Fernandez, Francisco
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2013, 155 (01) : 5 - 10
  • [43] Antiviral therapies for chronic hepatitis C virus infection with cirrhosis
    Shingo Nakamoto
    Tatsuo Kanda
    Hiroshi Shirasawa
    Osamu Yokosuka
    World Journal of Hepatology, 2015, (08) : 1133 - 1141
  • [44] The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection
    Kirdar, Sevin
    Sener, Asli Gamze
    Cengiz, Merve
    Aydin, Neriman
    APMIS, 2016, 124 (11) : 979 - 984
  • [45] Extrahepatic manifestations in patients with chronic hepatitis C virus infection
    Ramos-Casals, M
    Font, J
    CURRENT OPINION IN RHEUMATOLOGY, 2005, 17 (04) : 447 - 455
  • [46] Treatment of chronic hepatitis C virus infection in hemodialysis patients
    Kaya, Selcuk
    MIKROBIYOLOJI BULTENI, 2008, 42 (03): : 525 - 534
  • [47] Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection
    Mensa, Federico J.
    Lovell, Sandra
    Pilot-Matias, Tami
    Liu, Wei
    FUTURE MICROBIOLOGY, 2019, 14 (02) : 89 - 110
  • [48] Treatment of chronic hepatitis C virus infection in patients with cirrhosis
    Zeuzem, S
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (05) : 327 - 334
  • [49] Chronic hepatitis C virus infection associated with autonomic dysfunction
    Osztovits, Janos
    Horvath, Tamas
    Abonyi, Margit
    Toth, Tamas
    Visnyei, Zsolt
    Bekoe, Gabriella
    Csak, Timea
    Lakatos, Peter Laszlo
    Littvay, Levente
    Feher, Janos
    Kempler, Peter
    Kollai, Mark
    Szalay, Ferenc
    LIVER INTERNATIONAL, 2009, 29 (10) : 1473 - 1478
  • [50] Antiviral therapies for chronic hepatitis C virus infection with cirrhosis
    Nakamoto, Shingo
    Kanda, Tatsuo
    Shirasawa, Hiroshi
    Yokosuka, Osamu
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (08) : 1133 - 1141